Buy Axovant Gene Therapies Ltd Stock | AXGT Stock Price & Latest News | Public.com
AXGT

Axovant Gene Therapies Ltd

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Axovant Gene Therapies Ltd (AXGT) stock trends here

    About AXGT

    Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangli...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.17
    -0.25
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.20

    Actual EPS
    Q2 2021

    Stats

    Market Cap$101,24M
    Volume1,13M
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.74
    1 Year Low$1.41
    Open$2.59
    High$2.59
    Low$2.17

    Buy any stock with any amount of money.

    Download the App
    Download the app